CLINICAL_TRIALS
trial_result
· 2025-04-04
Clinical Trial Update: Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) [Phase 1]
Summary
KRYSTAL 2 is a Phase 1 trial evaluating adagrasib in combination with TNO155 in patients with advanced or metastatic cancer; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mirati Therapeutics Inc. | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED